Effects of the Start Time of Glycemic Control on Erectile Function in Streptozotocin-induced Diabetic Rats

Overview

Journal Int J Impot Res

Specialties Reproductive Medicine
Urology

Date 2016 Sep 23

PMID 27654033

Citations 1

Authors

O Kwon

S Y Cho

J-S Paick

S W Kim

Affiliations

Soon will be listed here.

Abstract

Diabetes-induced ED correlates with diabetes duration and glycemic control. This study evaluated the effect of glycemic control start time on erectile function in streptozotocin-induced diabetic rats. Rats were divided into normal controls (C); untreated diabetic rats (DM); and rats treated after 7 weeks (7W), and 10 weeks (10W) from DM. Treated diabetic rats received a timed daily injection of insulin. After 14 weeks of lab-controlled diabetes, experiments were performed. Group DM showed the ratio of intracavernosal pressure, significantly lower than other groups (10W vs DM; P<0.001). Groups 7W and 10W responded similarly, but did not recover to normal level (group C vs 7W; P<0.001). The percentage of α-smooth muscle actin increased more with earlier start times, and group DM's percentages decreased significantly (group 10W vs DM; P<0.001). Apoptosis recovered significantly only in group 7W, comparable to group C. As start times became earlier, for all molecules (eNOS, Akt, MYPT1 and PECAM-1), treatment groups' results neared those of group C. In conclusion, erectile function of diabetic rats recovered closer to normal controls if diabetic treatment started earlier. And the level of glycemic control was expected to be more important than the start time of diabetic treatment.

Citing Articles

Islet transplantation improved penile tissue fibrosis in a rat model of type 1 diabetes.

Wu Z, Wang H, Ni F, Jiang X, Xu Z, Liu C BMC Endocr Disord. 2018; 18(1):49.

PMID: 30053902 PMC: 6064149. DOI: 10.1186/s12902-018-0276-9.

References

. Standards of medical care in diabetes--2007. Diabetes Care. 2006; 30 Suppl 1:S4-S41. DOI: 10.2337/dc07-S004. View

Thompson E . Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatment. Am J Anat. 1988; 182(3):270-82. DOI: 10.1002/aja.1001820308. View

Sopko N, Hannan J, Bivalacqua T . Understanding and targeting the Rho kinase pathway in erectile dysfunction. Nat Rev Urol. 2014; 11(11):622-8. PMC: 4696116. DOI: 10.1038/nrurol.2014.278. View

. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006; 23(6):579-93. DOI: 10.1111/j.1464-5491.2006.01918.x. View

Romeo J, Seftel A, Madhun Z, Aron D . Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000; 163(3):788-91. View

Jensen V, Bogh I, Lykkesfeldt J . Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies. J Neuroendocrinol. 2014; 26(3):123-50. DOI: 10.1111/jne.12133. View

de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R . Pathophysiology of erectile dysfunction. J Sex Med. 2006; 2(1):26-39. DOI: 10.1111/j.1743-6109.2005.20103.x. View

Park K, Cho S, Kim S . Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes. Int J Androl. 2011; 34(5 Pt 2):e468-74. DOI: 10.1111/j.1365-2605.2011.01196.x. View

Awad H, Salem A, Gadalla A, El Wafa N, Mohamed O . Erectile function in men with diabetes type 2: correlation with glycemic control. Int J Impot Res. 2009; 22(1):36-9. DOI: 10.1038/ijir.2009.39. View

10.

Ryden L, Grant P, Anker S, Berne C, Cosentino F, Danchin N . ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in.... Eur Heart J. 2013; 34(39):3035-87. DOI: 10.1093/eurheartj/eht108. View

11.

Van Den Eeden S, Sarma A, Rutledge B, Cleary P, Kusek J, Nyberg L . Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care. 2009; 32(4):664-70. PMC: 2660483. DOI: 10.2337/dc07-2375. View

12.

Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E . Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care. 1998; 21(11):1973-7. DOI: 10.2337/diacare.21.11.1973. View

13.

Wang T, Yang J, Rao K, Zhan Y, Chen R, Liu Z . S-allyl cysteine restores erectile function through inhibition of reactive oxygen species generation in diabetic rats. Andrology. 2013; 1(3):487-94. DOI: 10.1111/j.2047-2927.2012.00060.x. View

14.

Bacon C, Hu F, Giovannucci E, Glasser D, Mittleman M, Rimm E . Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002; 25(8):1458-63. DOI: 10.2337/diacare.25.8.1458. View

15.

Wang L, Tian W, Uwais Z, Li G, Li H, Guan R . AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats. J Sex Med. 2014; 11(6):1452-62. DOI: 10.1111/jsm.12533. View

16.

Kern T, ENGERMAN R . Arrest of glomerulopathy in diabetic dogs by improved glycaemic control. Diabetologia. 1990; 33(9):522-5. DOI: 10.1007/BF00404138. View

17.

Greene D, Lattimer S, Ulbrecht J, Carroll P . Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care. 1985; 8(3):290-9. DOI: 10.2337/diacare.8.3.290. View

18.

Park K, Ryu K, Li W, Kim S, Paick J . Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol. 2008; 53(6):1282-8. DOI: 10.1016/j.eururo.2008.01.032. View

19.

Li W, Park K, Paick J, Kim S . Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats. J Sex Med. 2010; 8(2):400-10. DOI: 10.1111/j.1743-6109.2010.01724.x. View

20.

Cho S, Park K, Paick J, Kim S . Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats. J Sex Med. 2010; 8(5):1352-61. DOI: 10.1111/j.1743-6109.2010.02099.x. View